Healthcare provider profile · identity verified

Vincent P Sustersic, D.O.

Family Practice · BROADVIEW HTS, OH · NPI 1851329825

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	645	206
Losartan Potassium	Losartan Potassium	591	175
Amlodipine Besylate	Amlodipine Besylate	542	161
Levothyroxine Sodium	Levothyroxine Sodium	539	145
Simvastatin	Simvastatin	470	132
Rosuvastatin Calcium	Rosuvastatin Calcium	468	151
Lisinopril	Lisinopril	394	127
Alprazolam	Alprazolam	329	64
Metoprolol Succinate	Metoprolol Succinate	297	99
Hydrochlorothiazide	Hydrochlorothiazide	294	95
Gabapentin	Gabapentin	291	69
Pantoprazole Sodium	Pantoprazole Sodium	268	82
Metformin Hcl Er	Metformin Hcl	259	74
Glimepiride	Glimepiride	231	74
Omeprazole	Omeprazole	215	67
Azithromycin	Azithromycin	183	148
Metformin Hcl	Metformin Hcl	178	56
Atenolol	Atenolol	163	49
Metoprolol Tartrate	Metoprolol Tartrate	158	47
Fluticasone Propionate	Fluticasone Propionate	151	49
Tamsulosin Hcl	Tamsulosin Hcl	149	61
Trazodone Hcl	Trazodone Hcl	149	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	147	51
Allopurinol	Allopurinol	146	45
Albuterol Sulfate Hfa	Albuterol Sulfate	145	44
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	126	37
Furosemide	Furosemide	118	49
Lorazepam	Lorazepam	112	20
Eliquis	Apixaban	109	24
Sertraline Hcl	Sertraline Hcl	108	36
Meloxicam	Meloxicam	103	36
Escitalopram Oxalate	Escitalopram Oxalate	101	35
Pravastatin Sodium	Pravastatin Sodium	101	33
Diazepam	Diazepam	99	17
Duloxetine Hcl	Duloxetine Hcl	91	28
Prednisone	Prednisone	91	58
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	90	78
Potassium Chloride	Potassium Chloride	86	27
Xarelto	Rivaroxaban	83	23
Alendronate Sodium	Alendronate Sodium	80	27
Synthroid	Levothyroxine Sodium	79	25
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	76	56
Buspirone Hcl	Buspirone Hcl	75	20
Mirtazapine	Mirtazapine	74	24
Donepezil Hcl	Donepezil Hcl	71	18
Baclofen	Baclofen	70	22
Jardiance	Empagliflozin	68	21
Citalopram Hbr	Citalopram Hydrobromide	64	19
Ozempic	Semaglutide	64	11
Torsemide	Torsemide	64	30
Ibuprofen	Ibuprofen	63	18
Pioglitazone Hcl	Pioglitazone Hcl	63	20
Pregabalin	Pregabalin	63	12
Clonazepam	Clonazepam	62	suppressed
Ramipril	Ramipril	61	18
Zolpidem Tartrate	Zolpidem Tartrate	61	suppressed
Amoxicillin	Amoxicillin	60	39
Celecoxib	Celecoxib	59	16
Lovastatin	Lovastatin	59	20
Methylprednisolone	Methylprednisolone	59	49
Oxybutynin Chloride Er	Oxybutynin Chloride	57	20
Clopidogrel	Clopidogrel Bisulfate	55	20
Ondansetron Hcl	Ondansetron Hcl	55	15
Diclofenac Sodium	Diclofenac Sodium	54	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	19
Valsartan	Valsartan	54	15
Bupropion Xl	Bupropion Hcl	52	14
Paroxetine Hcl	Paroxetine Hcl	52	14
Montelukast Sodium	Montelukast Sodium	50	18
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	49	36
Dicyclomine Hcl	Dicyclomine Hcl	47	18
Hydralazine Hcl	Hydralazine Hcl	47	11
Venlafaxine Hcl Er	Venlafaxine Hcl	47	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	46	41
Tizanidine Hcl	Tizanidine Hcl	46	suppressed
Benazepril Hcl	Benazepril Hcl	45	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	suppressed
Ropinirole Hcl	Ropinirole Hcl	45	14
Methocarbamol	Methocarbamol	44	12
Carvedilol	Carvedilol	43	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	16
Hydrocortisone	Hydrocortisone	43	20
Famotidine	Famotidine	42	16
Finasteride	Finasteride	42	14
Meclizine Hcl	Meclizine Hcl	42	24
Temazepam	Temazepam	41	suppressed
Warfarin Sodium	Warfarin Sodium	41	13
Glipizide	Glipizide	40	suppressed
Glipizide Er	Glipizide	37	14
Testosterone	Testosterone	36	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	35	11
Januvia	Sitagliptin Phosphate	34	12
Fluoxetine Hcl	Fluoxetine Hcl	33	12
Memantine Hcl	Memantine Hcl	33	12
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Colchicine	Colchicine	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	28
Olmesartan Medoxomil	Olmesartan Medoxomil	29	11
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Fenofibrate	Fenofibrate	28	11
Fluconazole	Fluconazole	26	19
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Primidone	Primidone	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Armour Thyroid	Thyroid,pork	21	suppressed
Cephalexin	Cephalexin	21	20
Clonidine Hcl	Clonidine Hcl	21	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	14
Spironolactone	Spironolactone	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	13
Ezetimibe	Ezetimibe	20	suppressed
Naproxen	Naproxen	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Tramadol Hcl	Tramadol Hcl	18	11
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Nystatin	Nystatin	17	12
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Cilostazol	Cilostazol	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Topiramate	Topiramate	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Levofloxacin	Levofloxacin	15	14
Linzess	Linaclotide	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Ciclopirox	Ciclopirox Olamine	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Ibu	Ibuprofen	12	suppressed
Prolia	Denosumab	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	11	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	11	suppressed
Jantoven	Warfarin Sodium	11	suppressed
Rybelsus	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error